Pfizer Collaboration With University Of California Spawns New Research
This article was originally published in The Pink Sheet Daily
Executive Summary
Novel industry/academia partnership aims to speed tech transfer.
You may also be interested in...
Pfizer Signs Academic Collaboration Pact With Peking University To Support Translational R&D Center In Shenzhen
SHANGHAI - After unveiling a plan to build a research and development center in Wuhan last week, Pfizer announced it inked an agreement with Peking University Dec. 1 to fund the university's research projects and to build a translational research and drug discovery center in PKU's Graduate School in Shenzhen, a Chinese city that borders the former British enclave of Hong Kong
The J&J/ Vanderbilt Tie-Up: Accessing Innovation On The Cheap
With most Big Pharmas facing a steep and costly patent chasm and in-house R&D failing to produce the necessary bridge to patent-challenged franchises, companies have been forced to look for new sources of innovation beyond traditional in-licensing and acquisition. As a result, some drugmakers are looking with renewed interest at the innovation housed in universities. The tie-up between Johnson & Johnson and Vanderbilt University is just the latest example of this important trend.
Workforce Needs Top California Trade Group’s Policy Agenda
Meanwhile, bio industry looks to Obama for short-term financial relief amid economic crisis.